NCT04429620Unknown不适用
Prospective Assay for SARS-CoV-2 Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF Method
Szeged University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年5月30日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Sensitivity of the method by SARS-CoV2 ELISA compared
研究概览
简要总结
Prospective assay for SARS-CoV-2 antibody detection indirectly by immunofluorescence: SARS-CoV2 IIF method
详细描述
Sample preparation, serum separation by centrifugation
- 100 µl of serum for standard SARS-CoV2 ELISA is used according to the instructions for use.
- 100 µl of serum indirect immunofluorescent (IIF) method is used, the samples thus prepared analysis is performed under an automated microscope
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Other
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Person over 18 years of age
- •Signing a package leaflet and a informal consent
- •In the case of a positive group, confirmed by SARS-CoV2 qPCR Patient with COVID-19 or recovered individual.
- •In case of negative group by SARS-CoV2 qPCR test 2 negative in COVID-19 suffering individual
排除标准
- •Refuses to sign the consent form
结局指标
主要结局
Sensitivity of the method by SARS-CoV2 ELISA compared
时间窗: 8 months
Sensitivity of the method by SARS-CoV2 ELISA compared
次要结局
- Detectability of the antibodies IgA type against SARS-CoV2 virus(8 months)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19Covid19NCT04496141Hong Kong Sanatorium & Hospital70
已完成
不适用
Sustained Immunity to COVID-19 as Measured by SARS-CoV-2 Serology AssaysCovid19NCT04562285Henry Ford Health System829
终止
不适用
Detection and Characterization of Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster VaccinesAnti-SARS-CoV-2 Antibody ResponseNCT05142540Medical University of Graz140
已完成
不适用
Rapid Diagnostic Test for COVID-19 Based on Antibody Detection (YCOVID)Covid-19NCT04490837Corporacion Parc Tauli3,500
已完成
不适用
SARS-CoV-2 IgG and IgM Serologic AssaysCovid19NCT04562246Henry Ford Health System214